세계의 간염 진단 검사 시장 보고서(2025년)

Hepatitis diagnostic tests are medical procedures and laboratory analyses designed to identify and diagnose infections caused by hepatitis viruses, including hepatitis A, B, C, D, and E. These tests are essential for detecting the presence of hepatitis viruses or specific antibodies in a patient's blood or other bodily fluids. The primary goal is to confirm the infection, determine its type, assess severity, and monitor its progression.

The main categories of hepatitis diagnostic tests include blood tests, imaging tests, and liver biopsy. Blood tests involve examining blood samples to assess various constituents such as blood cells, proteins, enzymes, hormones, antibodies, and other chemicals. Various technologies are utilized in these tests, including enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), isothermal nucleic acid amplification tests, and others. These diagnostic tools find applications in diverse healthcare settings such as hospitals, diagnostic laboratories, blood banks, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hepatitis diagnostic tests market research report is one of a series of new reports from The Business Research Company that provides hepatitis diagnostic tests market statistics, including hepatitis diagnostic tests industry global market size, regional shares, competitors with a hepatitis diagnostic tests market share, detailed hepatitis diagnostic tests market segments, market trends, and opportunities, and any further data you may need to thrive in the hepatitis diagnostic test industry. This hepatitis diagnostic tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hepatitis diagnostic tests market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $4.93 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to globalization of healthcare, government initiatives, high disease burden, increased blood safety measures, public health campaigns.

The hepatitis diagnostic tests market size is expected to see strong growth in the next few years. It will grow to $6.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to global health security concerns, population growth and urbanization, tailored testing strategies, emphasis on elimination programs, increasing healthcare spending. Major trends in the forecast period include advancements in testing technologies, multiplex testing for different hepatitis viruses, integration of molecular diagnostics, digital health solutions, strategic collaborations and partnerships.

The forecast of 6.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of next-generation hepatitis screening by inflating prices of automated ELISA testing systems developed in Germany and Japan, resulting in slower diagnosis and higher public health intervention costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of blood transfusions and donations is expected to drive growth in the hepatitis diagnostic test market. Blood transfusions and donations are connected processes in which individuals voluntarily provide blood, which is then collected, tested, and administered to patients in need of additional blood components due to medical conditions, surgeries, accidents, or illnesses. Hepatitis diagnostic tests are essential for thoroughly screening blood before donation or transfusion, ensuring patient safety. For instance, in August 2023, the Royal College of Pathologists, a UK-based organization, reported that blood transfusion is the most commonly performed procedure for hospitalized patients, with nearly 2 million blood components issued and transfused annually in England, costing over £300 million ($390.69 million). Thus, the growing number of blood transfusions and donations supports the expansion of the hepatitis diagnostic test market.

The surge in hepatitis cases globally is another key factor propelling the growth of the hepatitis diagnostic tests market. Hepatitis, characterized by liver inflammation, poses significant health risks and can lead to various symptoms and complications. Accurate diagnostic tests for hepatitis are crucial in identifying and confirming the presence of hepatitis infections, enabling timely interventions and effective disease management. For instance, according to the Hepatitis B Foundation in 2023, an estimated 1.5 million people contract hepatitis infections annually, highlighting the persistent challenge posed by these diseases. The growing incidence of hepatitis underlines the critical importance of reliable diagnostic tests in early detection and management, thereby fueling the demand for hepatitis diagnostic tests in the market.

Dominant players in the hepatitis diagnostic test market are concentrating on innovating automated immunoassays, exemplified by the Elecsys HCV Duo, to enhance customer service reliability. Automated immunoassays represent laboratory techniques utilizing automated systems and specialized instruments to conduct various phases of the immunoassay process, encompassing sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, a biotechnology research company based in India, introduced Elecsys HCV Duo. This advanced solution represents India's maiden fully automated immunoassay available commercially, facilitating the simultaneous and independent evaluation of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. Moreover, this approach streamlines the diagnostic procedure, enabling single-specimen testing and potentially reducing the number of necessary follow-up visits, consequently alleviating the burden on healthcare systems.

In October 2024, The Bank of Nova Scotia, a Canada-based company, acquired Bio-Rad Laboratories Inc. for an undisclosed amount. This acquisition allows The Bank of Nova Scotia to diversify its portfolio by integrating Bio-Rad Laboratories' expertise in hepatitis diagnostic testing. Bio-Rad Laboratories Inc., a U.S.-based company, is known for its products and services in diagnostic testing for hepatitis.

Major companies operating in the hepatitis diagnostic tests market report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech PLC, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

North America was the largest region in the hepatitis diagnostic tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hepatitis diagnostic tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hepatitis diagnostic test market consists of revenues earned by entities by providing diagnostic services such as liver ultrasound, computerized tomography (CT) scans, and antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis diagnostic test market also includes sales of laboratory equipment, reagents, and assay components that are used in providing hepatitis diagnostic test services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hepatitis Diagnostic Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatitis diagnostic tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hepatitis diagnostic tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hepatitis diagnostic tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Blood Tests; Imaging Tests; Liver Biopsy
• 2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests (RDTs); Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Test (INAAT); Other Technologies
• 3) By End User: Hospitals; Diagnostic Laboratories; Blood Bank; Other End Users
• Subsegments:
• 1) By Blood Tests: Serological Tests; Polymerase Chain Reaction (PCR) Tests; Enzyme-Linked Immunosorbent Assays (ELISA)
• 2) By Imaging Tests: Ultrasound; Computed Tomography (CT); Magnetic Resonance Imaging (MRI)
• 3) By Liver Biopsy: Percutaneous Biopsy; Transjugular Biopsy; Laparoscopic Biopsy
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Roche Diagnostics; Quest Diagnostics Incorporated; Grifols S.A; Hologic Inc.; BioMerieux SA; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; SD Biosensor Co. Ltd.; QIAGEN N.V.; DiaSorin S.p.A.; Randox Laboratories Ltd.; Luminex Corporation; Fujirebio Diagnostics Inc.; Trivitron Healthcare Private Limited; Trinity Biotech plc; MP Biomedicals LLC; R-Biopharm AG; Creative Diagnostics; InBios International Inc.; Dia.Pro Diagnostic Bioprobes srl; DIALAB GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hepatitis Diagnostic Tests Market Characteristics

3. Hepatitis Diagnostic Tests Market Trends And Strategies

4. Hepatitis Diagnostic Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hepatitis Diagnostic Tests Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hepatitis Diagnostic Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hepatitis Diagnostic Tests Market Growth Rate Analysis
• 5.4. Global Hepatitis Diagnostic Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hepatitis Diagnostic Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hepatitis Diagnostic Tests Total Addressable Market (TAM)

6. Hepatitis Diagnostic Tests Market Segmentation

• 6.1. Global Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• Imaging Tests
• Liver Biopsy
• 6.2. Global Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests (RDTs)
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Test (INAAT)
• Other Technologies
• 6.3. Global Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Blood Bank
• Other End Users
• 6.4. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serological Tests
• Polymerase Chain Reaction (PCR) Tests
• Enzyme-Linked Immunosorbent Assays (ELISA)
• 6.5. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• 6.6. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Liver Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Percutaneous Biopsy
• Transjugular Biopsy
• Laparoscopic Biopsy

7. Hepatitis Diagnostic Tests Market Regional And Country Analysis

• 7.1. Global Hepatitis Diagnostic Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hepatitis Diagnostic Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hepatitis Diagnostic Tests Market

• 8.1. Asia-Pacific Hepatitis Diagnostic Tests Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hepatitis Diagnostic Tests Market

• 9.1. China Hepatitis Diagnostic Tests Market Overview
• 9.2. China Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hepatitis Diagnostic Tests Market

• 10.1. India Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hepatitis Diagnostic Tests Market

• 11.1. Japan Hepatitis Diagnostic Tests Market Overview
• 11.2. Japan Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hepatitis Diagnostic Tests Market

• 12.1. Australia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hepatitis Diagnostic Tests Market

• 13.1. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hepatitis Diagnostic Tests Market

• 14.1. South Korea Hepatitis Diagnostic Tests Market Overview
• 14.2. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hepatitis Diagnostic Tests Market

• 15.1. Western Europe Hepatitis Diagnostic Tests Market Overview
• 15.2. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hepatitis Diagnostic Tests Market

• 16.1. UK Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hepatitis Diagnostic Tests Market

• 17.1. Germany Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hepatitis Diagnostic Tests Market

• 18.1. France Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hepatitis Diagnostic Tests Market

• 19.1. Italy Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hepatitis Diagnostic Tests Market

• 20.1. Spain Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hepatitis Diagnostic Tests Market

• 21.1. Eastern Europe Hepatitis Diagnostic Tests Market Overview
• 21.2. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hepatitis Diagnostic Tests Market

• 22.1. Russia Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hepatitis Diagnostic Tests Market

• 23.1. North America Hepatitis Diagnostic Tests Market Overview
• 23.2. North America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hepatitis Diagnostic Tests Market

• 24.1. USA Hepatitis Diagnostic Tests Market Overview
• 24.2. USA Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hepatitis Diagnostic Tests Market

• 25.1. Canada Hepatitis Diagnostic Tests Market Overview
• 25.2. Canada Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hepatitis Diagnostic Tests Market

• 26.1. South America Hepatitis Diagnostic Tests Market Overview
• 26.2. South America Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hepatitis Diagnostic Tests Market

• 27.1. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hepatitis Diagnostic Tests Market

• 28.1. Middle East Hepatitis Diagnostic Tests Market Overview
• 28.2. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hepatitis Diagnostic Tests Market

• 29.1. Africa Hepatitis Diagnostic Tests Market Overview
• 29.2. Africa Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hepatitis Diagnostic Tests Market Competitive Landscape And Company Profiles

• 30.1. Hepatitis Diagnostic Tests Market Competitive Landscape
• 30.2. Hepatitis Diagnostic Tests Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Hepatitis Diagnostic Tests Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Grifols S.A
• 31.3. Hologic Inc.
• 31.4. BioMerieux SA
• 31.5. Beckman Coulter Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. SD Biosensor Co. Ltd.
• 31.8. QIAGEN N.V.
• 31.9. DiaSorin S.p.A.
• 31.10. Randox Laboratories Ltd.
• 31.11. Luminex Corporation
• 31.12. Fujirebio Diagnostics Inc.
• 31.13. Trivitron Healthcare Private Limited
• 31.14. Trinity Biotech plc
• 31.15. MP Biomedicals LLC

32. Global Hepatitis Diagnostic Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hepatitis Diagnostic Tests Market

34. Recent Developments In The Hepatitis Diagnostic Tests Market

35. Hepatitis Diagnostic Tests Market High Potential Countries, Segments and Strategies

• 35.1 Hepatitis Diagnostic Tests Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hepatitis Diagnostic Tests Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hepatitis Diagnostic Tests Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer